Skip to main content
TipRanks
Go Ultimate75% OFF

Invex Therapeutics Ltd. (IXC) Cash flow

2 Followers

Invex Therapeutics Ltd. Cash Flow

AU:IXC's free cash flow for Q4 2026 was AU$-579.12K. For the 2026 fiscal year, AU:IXC's free cash flow was increased by AU$0.00 and operating cash flow was AU$-579.12K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowJun 26Jun 25Jun 24Jun 23Jun 22
AU$ -1.36MAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38M
AU$ -2.50MAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
AU$ 0.00AU$ 0.00AU$ -14.00MAU$ 0.00AU$ 0.00
AU$ 1.52MAU$ 5.38MAU$ 6.03MAU$ 22.47MAU$ 29.34M
AU$ -1.36MAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38M

Currency in AUD

Invex Therapeutics Ltd. Cash Flow

-20M-10M010M20M20192020202120222023202420252026OperatingInvestingFinancing